Works matching AU Tracz, Amanda

Results: 9

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01825-8

By:

Pencik, Jan;
Philippe, Cecile;
Schlederer, Michaela;
Atas, Emine;
Pecoraro, Matteo;
Grund-Gröschke, Sandra;
Li, Wen;
Tracz, Amanda;
Heidegger, Isabel;
Lagger, Sabine;
Trachtová, Karolína;
Oberhuber, Monika;
Heitzer, Ellen;
Aksoy, Osman;
Neubauer, Heidi A.;
Wingelhofer, Bettina;
Orlova, Anna;
Witzeneder, Nadine;
Dillinger, Thomas;
Redl, Elisa

Publication type:

Article

Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2123, doi. 10.3390/ijms25042123

By:

Li, Wen;
Wang, Yunfei;
Liu, Xiaozhuo;
Wu, Shan;
Wang, Moyi;
Turowski, Steven G.;
Spernyak, Joseph A.;
Tracz, Amanda;
Abdelaal, Ahmed M.;
Sudarshan, Kasireddy;
Puzanov, Igor;
Chatta, Gurkamal;
Kasinski, Andrea L.;
Tang, Dean G.

Publication type:

Article

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy.

Published in:

EMBO Molecular Medicine, 2014, v. 6, n. 12, p. 1561, doi. 10.15252/emmm.201403989

By:

Ebos, John ML;
Mastri, Michalis;
Lee, Christina R;
Tracz, Amanda;
Hudson, John M;
Attwood, Kristopher;
Cruz‐Munoz, William R;
Jedeszko, Christopher;
Burns, Peter;
Kerbel, Robert S

Publication type:

Article

Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.

Published in:

PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220101

By:

Dolan, Melissa;
Mastri, Michalis;
Tracz, Amanda;
Christensen, James G.;
Chatta, Gurkamal;
Ebos, John M. L.

Publication type:

Article

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth.

Published in:

PLoS Computational Biology, 2014, v. 10, n. 8, p. 1, doi. 10.1371/journal.pcbi.1003800

By:

Benzekry, Sébastien;
Lamont, Clare;
Beheshti, Afshin;
Tracz, Amanda;
Ebos, John M. L.;
Hlatky, Lynn;
Hahnfeldt, Philip

Publication type:

Article

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.

Published in:

Nature Communications, 2018, p. 1, doi. 10.1038/s41467-018-06067-7

By:

Qiuhui Li;
Qu Deng;
Hsueh-Ping Chao;
Xin Liu;
Yue Lu;
Kevin Lin;
Bigang Liu;
Tang, Gregory W.;
Dingxiao Zhang;
Tracz, Amanda;
Jeter, Collene;
Rycaj, Kiera;
Calhoun-Davis, Tammy;
Jiaoti Huang;
Rubin, Mark A.;
Beltran, Himisha;
Jianjun Shen;
Chatta, Gurkamal;
Puzanov, Igor;
Mohler, James L.

Publication type:

Article

Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.

Published in:

2020

By:

Li, Qiuhui;
Liu, Bigang;
Chao, Hsueh-Ping;
Ji, Yibing;
Lu, Yue;
Mehmood, Rashid;
Jeter, Collene;
Chen, Taiping;
Moore, John R.;
Li, Wenqian;
Liu, Can;
Rycaj, Kiera;
Tracz, Amanda;
Kirk, Jason;
Calhoun-Davis, Tammy;
Xiong, Jie;
Deng, Qu;
Huang, Jiaoti;
Foster, Barbara A.;
Gokhale, Abhiram

Publication type:

Correction Notice

Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer.

Published in:

Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15815-7

By:

Zhang, Dingxiao;
Hu, Qiang;
Liu, Xiaozhuo;
Ji, Yibing;
Chao, Hsueh-Ping;
Liu, Yan;
Tracz, Amanda;
Kirk, Jason;
Buonamici, Silvia;
Zhu, Ping;
Wang, Jianmin;
Liu, Song;
Tang, Dean G.

Publication type:

Article

LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.

Published in:

Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-13532-4

By:

Li, Qiuhui;
Liu, Bigang;
Chao, Hsueh-Ping;
Ji, Yibing;
Lu, Yue;
Mehmood, Rashid;
Jeter, Collene;
Chen, Taiping;
Moore, John R.;
Li, Wenqian;
Liu, Can;
Rycaj, Kiera;
Tracz, Amanda;
Kirk, Jason;
Calhoun-Davis, Tammy;
Xiong, Jie;
Deng, Qu;
Huang, Jiaoti;
Foster, Barbara A.;
Gokhale, Abhiram

Publication type:

Article